Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

• मुख्य लेखकों: Dongxuan Li (लेखक), Chunmeng Qin (लेखक), Hongli Wang (लेखक), Dan Du (लेखक), Yalan Wang (लेखक), Qian Du (लेखक), Songqing Liu (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: SAGE Publishing, 2024-09-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: The use of antineoplastic agents is one of the important triggers of tumor lysis syndrome (TLS), but there is still a lack of comprehensive understanding of antineoplastic agents that may trigger TLS and the TLS risk differences between different antineoplastic agents. Objectives: This s...